References 1. Stevens W, Kaye S, Corrah T. Antiretroviral therapy in Africa. BMJ 2004;328: 280-2.[Free Full Text] 2. Yazdanpanah Y, Sissoko D, Egger M, Mouton Y, Zwahlen M, Chene G. Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials. BMJ 2004;328: 249-52. 3. Kumar S. India's treatment programme for AIDS is premature. BMJ 2004;328: 70.[Free Full Text] 4. McCoy D. HIV care and treatment in southern Africa: addressing equity. Harare: EQUINET and OXFAM GB, 2003. (EQUINET discussion paper No 10.) 5. Ray S, Kureya T. Zimbabwe's challenge: equity in health sector responses to HIV/AIDS in Zimbabwe. Harare: EQUINET and OXFAM GB, 2003. (EQUINET discussion paper No 9.) 6. Ntuli A, Ijumba P, McCoy D, Padarath A, Berthiaume L. HIV/AIDS and health sector responses in South Africa. Treatment access and equity: balancing the act. Harare: EQUINET and OXFAM GB, 2003. (EQUINET discussion paper No 7.) 7. Kemp. J, Aitken JM, LeGrand S, Mwale B. Equity in health sector responses to HIV/AIDS in Malawi. (EQUINET discussion paper No 6.) 8. EQUINET Steering Committee. Equity in health in southern Africa: turning values into practice. Harare: EQUINET, 2000. (Policy series No 7.) 9. Aitken JM, Kemp J. HIV/AIDS, equity and health sector personnel in southern Africa. Harare: EQUINET and OXFAM GB, 2003. (EQUINET discussion paper No 12.)